Broad Institute presses for CRISPR settlement after EPO revocation

23-01-2020

Rory O'Neill

Broad Institute presses for CRISPR settlement after EPO revocation

servickuz / shutterstock.com

A competitor of the Broad Institute has said that a European Patent Office (EPO) ruling last week has weakened the CRISPR/Cas9 patent owner’s negotiating hand in any future settlement between the parties.


ERS Genomics, Broad Institute, CRISPR/Cas9, Eric Rhodes, Emmannuelle Charpentier, settlement

More on this story

Breaking: EPO revokes Broad’s CRISPR patent
16-01-2020

LSIPR